Skip to main content

Active filters: Validation (5 posts)

Clear filters
The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control
News Pinned

The First FDA Warning Letter Referencing AI: Why the Failure Was Not the Technology, but the Lack of Control

The first FDA Warning Letter explicitly referencing the use of Artificial Intelligence is making waves across the industry. But a closer look reveals: the failure was not the technology itself, but the lack of control around it. Missing validation, insufficient documentation, and poor process integration — the actual weaknesses are well-known GMP issues.

Warning Letter analyzed in detail
Create GxP-compliant EBR recipes in minutes instead of months!
News

Flexible EBR in the regulated pharmaceutical environment – GxP-compliant and future-proof

The pharmaceutical industry is facing major challenges: Strict regulations (validation, ER/ES, audit trail, data integrity, data consistency, etc.) must be met, while at the same time customers expect innovation, fast delivery times and a broad product range – all while maintaining consistently high, defined quality.

What if the first step to solving your challenges could be found in this article?

Read article